CHASE WILLIAM J
Insider CIK 1563572 · ABBV EVP, Finance & Administration · NTLA Director · GRAL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRAL GRAIL, Inc. | A Award | 2026-10-15 | 2026-10-16 | 153 | $135.46 | $20.7K | 43,131 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2026-07-15 | 2026-07-16 | 276 | $74.36 | $20.5K | 42,978 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2026-06-18 | 2026-06-22 | 5,491 | $63.74 | $350.0K | 42,702 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 143,893 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2026-04-15 | 2026-04-17 | 408 | $49.79 | $20.3K | 37,211 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2026-01-15 | 2026-01-16 | 213 | $97.44 | $20.8K | 36,803 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2025-10-15 | 2025-10-16 | 275 | $75.52 | $20.8K | 36,590 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2025-08-20 | 2025-08-22 | 100,000 | $10.03 | $1.00M | 134,693 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2025-07-15 | 2025-07-17 | 533 | $38.53 | $20.5K | 36,315 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 34,693 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2025-05-29 | 2025-05-30 | 6,082 | $41.10 | $250.0K | 35,782 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2025-04-15 | 2025-04-16 | 784 | $25.94 | $20.3K | 29,700 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2025-01-15 | 2025-01-16 | 1,182 | $17.58 | $20.8K | 28,916 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2024-10-30 | 2024-11-01 | 210 | $13.62 | $2.9K | 27,734 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2024-10-15 | 2024-10-17 | 1,054 | $14.01 | $14.8K | 27,524 | SEC↗ |
| GRAL GRAIL, Inc. | A Award | 2024-06-25 | 2024-06-27 | 26,470 | — | $0 | 26,470 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 26,693 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-06-14 | 2023-06-16 | 2,447 | — | $0 | 2,447 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-06-14 | 2023-06-16 | 1,673 | — | $0 | 18,956 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-04-14 | 2023-04-18 | 14,931 | — | $0 | 14,931 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-04-14 | 2023-04-18 | 10,483 | — | $0 | 17,283 | SEC↗ |
| ABBV AbbVie Inc. | P Buy | 2019-06-26 | 2019-06-28 | 30,400 | $67.30 | $2.05M | 169,552 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2019-02-28 | 2019-03-04 | 27,276 | $79.41 | $2.17M | 139,152 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2019-02-21 | 2019-02-22 | 60,747 | — | $0 | 60,747 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 22,150 | — | $0 | 127,013 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 8,481 | — | $0 | 166,428 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 14,989 | — | $0 | 157,947 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 15,945 | — | $0 | 142,958 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-12-12 | 2018-12-14 | 60,000 | $90.00 | $5.40M | 104,863 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2018-03-01 | 2018-03-02 | 13,400 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2018-03-01 | 2018-03-02 | 19,000 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2018-03-01 | 2018-03-02 | 13,400 | $28.31 | $379.4K | 178,263 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2018-03-01 | 2018-03-02 | 19,000 | $24.21 | $460.0K | 197,263 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-03-01 | 2018-03-02 | 32,400 | $114.50 | $3.71M | 164,863 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2018-02-28 | 2018-03-02 | 28,407 | $118.26 | $3.36M | 203,391 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-02-28 | 2018-03-02 | 38,528 | $119.44 | $4.60M | 164,863 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 45,840 | — | $0 | 45,840 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 15,945 | — | $0 | 199,488 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 17,319 | — | $0 | 216,807 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 14,991 | — | $0 | 231,798 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2017-05-18 | 2017-05-19 | 25,500 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2017-05-18 | 2017-05-19 | 12,800 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-05-18 | 2017-05-19 | 38,300 | $65.35 | $2.50M | 183,543 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2017-05-18 | 2017-05-19 | 25,500 | $28.86 | $735.9K | 209,043 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2017-05-18 | 2017-05-19 | 12,800 | $28.13 | $360.1K | 221,843 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 40,212 | $62.22 | $2.50M | 183,543 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 100,100 | — | $0 | 100,100 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 35,440 | — | $0 | 207,810 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 15,945 | — | $0 | 223,755 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2016-12-02 | 2016-12-02 | 6,600 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2016-12-02 | 2016-12-02 | 6,600 | $59.19 | $390.7K | 172,370 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2016-12-02 | 2016-12-02 | 6,600 | $27.29 | $180.1K | 178,970 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2016-02-29 | 2016-03-02 | 45,658 | $56.00 | $2.56M | 172,370 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2016-02-18 | 2016-02-22 | 95,400 | — | $0 | 95,400 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-28 | 2015-03-03 | 8,192 | $60.50 | $495.6K | 218,028 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-27 | 2015-03-03 | 10,299 | $60.52 | $623.3K | 226,220 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2015-02-19 | 2015-02-23 | 110,770 | — | $0 | 110,770 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2015-02-19 | 2015-02-23 | 56,040 | — | $0 | 236,519 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2014-12-22 | 2014-12-22 | 8,495 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2014-12-22 | 2014-12-22 | 8,495 | $24.07 | $204.5K | 188,563 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-12-22 | 2014-12-22 | 8,495 | $68.00 | $577.7K | 180,068 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 100 | $51.20 | $5.1K | 180,068 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 1,400 | $50.19 | $70.3K | 180,168 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 2,448 | $50.19 | $122.9K | 181,568 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2014-02-28 | 2014-03-04 | 9,873 | $51.91 | $512.5K | 184,016 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2014-02-20 | 2014-02-24 | 92,740 | — | $0 | 92,740 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2014-02-20 | 2014-02-24 | 53,770 | — | $0 | 193,889 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 1,591 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 1,620 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 963 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 3,438 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 3,438 | $35.99 | $123.7K | 146,268 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 1,620 | $34.49 | $55.9K | 141,239 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-12-19 | 2013-12-20 | 6,149 | $54.32 | $334.0K | 140,119 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 963 | $28.97 | $27.9K | 139,619 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 1,591 | $35.24 | $56.1K | 142,830 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-28 | 2013-03-04 | 5,260 | $36.73 | $193.2K | 138,656 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-19 | 2013-02-19 | 2,912 | $37.58 | $109.4K | 143,916 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2013-02-14 | 2013-02-19 | 115,830 | — | $0 | 115,830 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2013-02-14 | 2013-02-19 | 56,700 | — | $0 | 146,828 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-02-07 | 2013-02-08 | 2,177 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-02-07 | 2013-02-08 | 2,390 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-07 | 2013-02-08 | 4,188 | $37.14 | $155.5K | 90,128 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-02-07 | 2013-02-08 | 2,177 | $32.43 | $70.6K | 94,316 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-02-07 | 2013-02-08 | 2,390 | $32.00 | $76.5K | 92,139 | SEC↗ |